Locations:
SearchHow Cleveland Clinic cut time to treat in half for breast cancer patients
Efforts to address time to treat at Cleveland Clinic Cancer Center have cut almost in half the time breast cancer patients wait between diagnosis and treatment. Taussig Cancer Institute chairman Brian Bolwell, MD, FACP, discusses Cleveland Clinic Cancer Center’s commitment to reducing time to treat to less than half the national average across all diagnoses in the video below:
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Video content: This video is available to watch online.
View video online (https://www.youtube.com/embed/0h03mjjFvVw?feature=oembed)
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients